Genesis Healthcare Inc. Stock
Price
Target price
-
-
-
-
-
?32.07
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Genesis Healthcare Inc. Stock
Genesis Healthcare Inc. is currently one of the favorites of our community with 7 Buy predictions and no Sell predictions.
Based on the current price of 0.38 € the target price of 32 € shows a potential of 8321.05% for Genesis Healthcare Inc. which would more than double the current price.
Pros and Cons of Genesis Healthcare Inc. in the next few years
Pros
?
B****
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
S********** s********
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Genesis Healthcare Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Genesis Healthcare Inc. | - | - | - | - | - | - | - |
| Capital Senior Living Corp. | -1.200% | 0.000% | 11.348% | 31.933% | 16.296% | - | - |
| Healthstream Inc. | -0.510% | 1.538% | 15.116% | -18.852% | 1.538% | -9.174% | -7.477% |
| Evolent Health Inc | -1.130% | 9.317% | 62.963% | -57.073% | 2.924% | -89.202% | - |
Comments
Gen Digital (GEN) was upgraded by Wall Street Zen from "hold" to "buy".
Show more
Ratings data for GEN provided by MarketBeat
Gen Digital (GEN) was upgraded by Jefferies Financial Group Inc. from "hold" to "strong-buy".
Show more
Ratings data for GEN provided by MarketBeat
Gen Digital (NASDAQ:GEN) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for GEN provided by MarketBeat
News
Cellebrite DI Q1 Earnings Call Highlights
Cellebrite DI (NASDAQ:CLBT) reported first-quarter 2026 results that management said met or exceeded the high end of its guidance for annual recurring revenue and adjusted EBITDA, while executives
Genesis Energy Q1 Earnings Call Highlights
Genesis Energy (NYSE:GEL) said first-quarter 2026 results came in “a touch below” its internal expectations, primarily due to anticipated offshore producer turnarounds, lower-than-expected
5 Energy Stocks That Could Benefit From the Genesis Mission
President Trump recently announced an executive order to initiate the Genesis Mission, a federal initiative under the Department of Energy, aimed at accelerating the development of artificial
